Perhaps ME/CFS patients need to write to the regulators in the UK and the US, who are clamping down on GcMAF because of the cancer cure claims.
However, these regulators may not be aware that GcMAF is helping some ME/CFS patients, and that by making it hard for companies to manufacture and supply GcMAF, they are also affecting the ME/CFS community.
However, these regulators may not be aware that GcMAF is helping some ME/CFS patients, and that by making it hard for companies to manufacture and supply GcMAF, they are also affecting the ME/CFS community.